Effects of Dexrazoxane Hydrochloride on Biomarkers Associated With Cardiomyopathy and Heart Failure After Cancer Treatment
Status: | Recruiting |
---|---|
Conditions: | Cancer, Cancer, Cancer, Blood Cancer, Cardiology, Lymphoma |
Therapuetic Areas: | Cardiology / Vascular Diseases, Oncology |
Healthy: | No |
Age Range: | Any |
Updated: | 2/24/2019 |
Start Date: | August 5, 2013 |
Health Effects After Anthracycline and Radiation Therapy (HEART): Dexrazoxane and Prevention of Anthracycline-Related Cardiomyopathy
This clinical trial studies the effects of dexrazoxane hydrochloride on biomarkers associated
with cardiomyopathy and heart failure after cancer treatment. Studying samples of blood in
the laboratory from patients receiving dexrazoxane hydrochloride may help doctors learn more
about the effects of dexrazoxane hydrochloride on cells. It may also help doctors understand
how well patients respond to treatment.
with cardiomyopathy and heart failure after cancer treatment. Studying samples of blood in
the laboratory from patients receiving dexrazoxane hydrochloride may help doctors learn more
about the effects of dexrazoxane hydrochloride on cells. It may also help doctors understand
how well patients respond to treatment.
PRIMARY OBJECTIVES:
I. To determine whether leukemia and lymphoma patients from P9404, P9425, P9426, and Dana
Farber Cancer Institute (DFCI) 95-01 randomized to the experimental dexrazoxane hydrochloride
(DRZ) arms have decreased markers of cardiomyopathy/heart failure (CHF) compared with
patients on the standard arm.
II. To determine whether osteosarcoma patients from P9754 (all received DRZ) have decreased
markers of cardiomyopathy/heart failure (CHF) compared with similarly treated osteosarcoma
patients diagnosed during the same time period, but who did not receive DRZ.
III. To evaluate whether the cardioprotective effect of DRZ is modified by anthracycline
(anthracycline analogue GPX-150) dose, chest radiation, and demographic factors (age at
cancer diagnosis, current age, sex).
SECONDARY OBJECTIVES:
I. To determine whether leukemia and lymphoma patients from P9404, P9425, P9426, and DFCI
95-01 on the DRZ arms experienced differential rates of overall-survival and event-free
survival compared with the standard therapy arms.
II. To determine whether projected quality-adjusted life years (QALY) differed by DRZ status,
accounting for premature cardiac disease, primary disease relapse, and second cancers.
OUTLINE:
Patients complete a diagnostic symptom checklist, undergo a physical exam, echocardiogram,
collection of serum for biomarker testing, and a 6 minute walk test, and complete quality of
life, family history, physical activity, and smoking questionnaires.
I. To determine whether leukemia and lymphoma patients from P9404, P9425, P9426, and Dana
Farber Cancer Institute (DFCI) 95-01 randomized to the experimental dexrazoxane hydrochloride
(DRZ) arms have decreased markers of cardiomyopathy/heart failure (CHF) compared with
patients on the standard arm.
II. To determine whether osteosarcoma patients from P9754 (all received DRZ) have decreased
markers of cardiomyopathy/heart failure (CHF) compared with similarly treated osteosarcoma
patients diagnosed during the same time period, but who did not receive DRZ.
III. To evaluate whether the cardioprotective effect of DRZ is modified by anthracycline
(anthracycline analogue GPX-150) dose, chest radiation, and demographic factors (age at
cancer diagnosis, current age, sex).
SECONDARY OBJECTIVES:
I. To determine whether leukemia and lymphoma patients from P9404, P9425, P9426, and DFCI
95-01 on the DRZ arms experienced differential rates of overall-survival and event-free
survival compared with the standard therapy arms.
II. To determine whether projected quality-adjusted life years (QALY) differed by DRZ status,
accounting for premature cardiac disease, primary disease relapse, and second cancers.
OUTLINE:
Patients complete a diagnostic symptom checklist, undergo a physical exam, echocardiogram,
collection of serum for biomarker testing, and a 6 minute walk test, and complete quality of
life, family history, physical activity, and smoking questionnaires.
Inclusion Criteria:
- STRATUM I AND STRATUM II: LEUKEMIA AND LYMPHOMA SURVIVORS
- Previously enrolled leukemia and lymphoma survivors, randomized to + or - DRZ on
P9404, P9425, P9426, or DFCI 95-01 (high-risk patients only)
- STRATUM I: Alive and in continuous first complete remission from their original cancer
(leukemia/lymphoblastic lymphoma [P9404, high-risk DFCI 95-01] or Hodgkin lymphoma
[P9425/P9426])
- STRATUM I: Did not have progressive disease or induction failure requiring
off-protocol therapy including hematopoietic cell transplantation
- STRATUM I: Must not have been diagnosed with any subsequent malignancy that required
additional cardiotoxic therapies (i.e., radiotherapy to the chest [also includes
fields directed towards the neck, upper abdomen, or spine], or additional
anthracyclines or anthraquinones); patients with history of subsequent malignancy that
did not require such therapies remain eligible
- STRATUM I: All patients and/or their parents or legal guardians must sign a written
informed consent
- STRATUM II: Among leukemia and lymphoma patients randomized to + or - DRZ on P9404,
P9425, P9426, and DFCI 95-01 (high risk patients only) who have relapsed or have
experienced a subsequent malignancy that precludes eligibility since their original
diagnosis, the study committee will review the available data (both from Children's
Oncology Group's [COG?s] Statistics and Data Center [SDC] and the participating
institution) to determine if individual patients are to be selected for Stratum 2; in
recognition that local institutions sometimes have more updated relapse/subsequent
cancer data than SDC, in cases where local data is more updated, local data will be
used preferentially; the study will petition the Institutional Review Board (IRB)
specifically for a waiver of consent to include any relapse and subsequent cancer data
obtained from existing records for analysis of the secondary aims; patients selected
for Stratum 2 will be those for whom late relapse or subsequent cancer is reported but
who lack clear confirmation in existing records (either at SDC or at the local
institution)
- STRATUM II: Alive, but have experienced relapse of their original cancer and/or have
developed a subsequent cancer (other than non-melanomatous skin cancer) since their
original diagnosis
- STRATUM II: All patients and/or their parents or legal guardians must sign a written
informed consent
- STRATUM III: OSTEOSARCOMA SURVIVORS
- Previously enrolled osteosarcoma survivors treated on P9754 who are alive and able
(themselves and/or parents/legal guardian) to provide written informed consent; note
that relapse and subsequent malignancy are not exclusion criteria for P9754 survivors
- Comparison subjects for P9754 survivors will be eligible to be enrolled from any
ALTE11C2 participating COG site (even if that institution did not participate on
P9754), according to the following criteria:
- Newly diagnosed, previously untreated biopsy-proven moderate or high grade
osteosarcoma without metastasis; patients with low grade osteosarcoma, parosteal
or periosteal sarcoma are ineligible
- < 31 years of age at time of initial osteosarcoma diagnosis
- Diagnosis occurred between January 1, 1999 through December 31, 2002; duration of
therapy can extend beyond 2002
- No evidence of poor or low cardiac function at time of initial osteosarcoma
diagnosis; if reports from the time are available: shortening fraction >= 28% by
echocardiogram and within the institutional normative range for age, or
radionuclide angiogram ejection fraction >= 50%; if imaging reports from the time
are no longer available, there must be no documentation within available medical
records that suggest poor or low cardiac function at time of diagnosis
- Comparison subject must have institutional records (e.g., clinic note, treatment
summary, chemotherapy roadmap) documenting lifetime receipt of 450 to 600 mg/m^2
of doxorubicin (doses within 10% are acceptable); this includes initial therapy
as well as any subsequent therapy for relapse or second cancer, if relevant; as
such, comparison subjects who have had osteosarcoma relapse or subsequent
malignancies remain eligible so long as they meet all other eligibility criteria
- No anthracycline or anthraquinone aside from doxorubicin was ever given as part
of initial or subsequent therapies
- No exposure to DRZ at any point in time
- All patients and/or their parents or legal guardians must sign a written informed
consent
- For all participants, all institutional, Food and Drug Administration (FDA), and
National Cancer Institute (NCI) requirements for human studies must be met
We found this trial at
63
sites
Syracuse, New York 13214
Principal Investigator: Philip M. Monteleone
Phone: 315-464-5476
Click here to add this to my saved trials
1201 Camino de Salud Northeast
Albuquerque, New Mexico 87131
Albuquerque, New Mexico 87131
(505) 272-4946
Principal Investigator: John F. Kuttesch
Phone: 505-925-0366
University of New Mexico Cancer Center It’s been 40 years since the New Mexico State...
Click here to add this to my saved trials
1600 7th Avenue
Birmingham, Alabama 35233
Birmingham, Alabama 35233
(205) 638-9100
Principal Investigator: Matthew A. Kutny
Phone: 205-975-1941
Children's Hospital of Alabama Children
Click here to add this to my saved trials
666 Elm Street
Buffalo, New York 14263
Buffalo, New York 14263
(716) 845-2300
Principal Investigator: Denise A. Rokitka
Phone: 800-767-9355
Roswell Park Cancer Institute Welcome to Roswell Park Cancer Institute (RPCI), America's first cancer center...
Click here to add this to my saved trials
1 South Prospect Street
Burlington, Vermont 05401
Burlington, Vermont 05401
802-656-8990
Principal Investigator: Jessica L. Heath
Click here to add this to my saved trials
3333 Burnet Avenue # Mlc3008
Cincinnati, Ohio 45229
Cincinnati, Ohio 45229
1-513-636-4200
Principal Investigator: Rajaram Nagarajan
Cincinnati Children's Hospital Medical Center Patients and families from across the region and around the...
Click here to add this to my saved trials
7777 Forest Ln # C840
Dallas, Texas 75230
Dallas, Texas 75230
(972) 566-7000
Principal Investigator: Carl Lenarsky
Phone: 972-566-5588
Medical City Dallas Hospital If you have concerns for your health, that of a family...
Click here to add this to my saved trials
1500 E Duarte Rd
Duarte, California 91010
Duarte, California 91010
(626) 256-4673
Principal Investigator: Saro H. Armenian
Phone: 800-826-4673
City of Hope Comprehensive Cancer Center City of Hope is a leading research and treatment...
Click here to add this to my saved trials
1 Hurley Plaza
Flint, Michigan 48503
Flint, Michigan 48503
(810) 262-9000
Principal Investigator: Nkechi Onwuzurike
Phone: 888-606-6556
Hurley Medical Center From its founding in 1908, Hurley Medical Center has devoted itself to...
Click here to add this to my saved trials
2500 N State St
Jackson, Mississippi 39216
Jackson, Mississippi 39216
(601) 984-1000
Principal Investigator: Gail C. Megason
Phone: 601-815-6700
University of Mississippi Medical Center The University of Mississippi Medical Center, located in Jackson, is...
Click here to add this to my saved trials
530 Northeast Glen Oak Avenue
Peoria, Illinois 61603
Peoria, Illinois 61603
(309) 624-4945
Principal Investigator: Pedro A. De Alarcon
Phone: 888-226-4343
Saint Jude Midwest Affiliate The Jim and Trudy Maloof St. Jude Midwest Affiliate Clinic was...
Click here to add this to my saved trials
3181 Southwest Sam Jackson Park Road
Portland, Oregon 97239
Portland, Oregon 97239
503 494-8311
Principal Investigator: Susan J. Lindemulder
Phone: 503-494-1080
Oregon Health and Science University In 1887, the inaugural class of the University of Oregon...
Click here to add this to my saved trials
593 Eddy Street
Providence, Rhode Island 02903
Providence, Rhode Island 02903
401-444-4000
Principal Investigator: Jennifer J. Greene Welch
Phone: 401-444-1488
Rhode Island Hospital Founded in 1863, Rhode Island Hospital in Providence, RI, is a private,...
Click here to add this to my saved trials
401 College Street
Richmond, Virginia 23298
Richmond, Virginia 23298
(804) 828-0450
Principal Investigator: Madhu S. Gowda
Phone: 804-628-1939
Virginia Commonwealth University Massey Cancer Center Founded in 1974, VCU Massey Cancer Center is a...
Click here to add this to my saved trials
60 Crittenden Blvd # 70
Rochester, New York 14642
Rochester, New York 14642
(585) 275-2121
Principal Investigator: Angela R. Girvin
Phone: 585-275-5830
University of Rochester The University of Rochester is one of the country's top-tier research universities....
Click here to add this to my saved trials
4502 Medical Drive
San Antonio, Texas 78284
San Antonio, Texas 78284
(210) 567-7000
Principal Investigator: Anne-Marie R. Langevin
Phone: 210-450-3800
University of Texas Health Science Center at San Antonio The University of Texas Health Science...
Click here to add this to my saved trials
3020 Childrens way
San Diego, California 92123
San Diego, California 92123
(858) 576-1700
Principal Investigator: William D. Roberts
Phone: 858-966-5934
Rady Children's Hospital - San Diego Rady Children's Hospital-San Diego is the region’s pediatric medical...
Click here to add this to my saved trials
Akron, Ohio 44308
Principal Investigator: Steven J. Kuerbitz
Phone: 330-543-3193
Click here to add this to my saved trials
Asheville, North Carolina 28801
Principal Investigator: Douglas J. Scothorn
Phone: 828-213-4150
Click here to add this to my saved trials
Atlanta, Georgia 30322
Principal Investigator: Lillian R. Meacham
Phone: 404-785-1112
Click here to add this to my saved trials
2401 W Belvedere Ave
Baltimore, Maryland 21215
Baltimore, Maryland 21215
(410) 601-9000
Principal Investigator: Jason M. Fixler
Phone: 410-601-6120
Sinai Hospital of Baltimore Sinai Hospital of Baltimore provides a broad array of high-quality, cost-effective...
Click here to add this to my saved trials
401 North Broadway
Baltimore, Maryland 21287
Baltimore, Maryland 21287
410-955-5000
Principal Investigator: Kenneth J. Cohen
Phone: 410-955-8804
Johns Hopkins University-Sidney Kimmel Cancer Center The name Johns Hopkins has become synonymous with excellence...
Click here to add this to my saved trials
450 Brookline Ave
Boston, Massachusetts 2215
Boston, Massachusetts 2215
617-632-3000
Principal Investigator: Lynda M. Vrooman
Phone: 877-442-3324
Dana-Farber Cancer Institute Since it’s founding in 1947, Dana-Farber has been committed to providing adults...
Click here to add this to my saved trials
171 Ashley Avenue
Charleston, South Carolina 29425
Charleston, South Carolina 29425
843-792-1414
Principal Investigator: Jacqueline M. Kraveka
Phone: 843-792-9321
Medical University of South Carolina The Medical University of South Carolina (MUSC) has grown from...
Click here to add this to my saved trials
Chicago, Illinois 60614
Principal Investigator: Jennifer L. Reichek
Phone: 773-880-4562
Click here to add this to my saved trials
1200 West Harrison Stree
Chicago, Illinois 60607
Chicago, Illinois 60607
(312) 996-4350
Principal Investigator: Mary L. Schmidt
Phone: 312-355-3046
Univ of Illinois A major research university in the heart of one of the world's...
Click here to add this to my saved trials
Columbia, Missouri 65201
Principal Investigator: Thomas W. Loew
Phone: 573-882-7440
Click here to add this to my saved trials
Dallas, Texas 75390
Principal Investigator: Daniel C. Bowers
Phone: 214-648-7097
Click here to add this to my saved trials
4160 John R St #2122
Detroit, Michigan 48201
Detroit, Michigan 48201
(313) 833-1785
Wayne State University/Karmanos Cancer Institute Karmanos is based in southeast Michigan, in midtown Detroit, and...
Click here to add this to my saved trials
Detroit, Michigan 48236
Principal Investigator: Adonis N. Lorenzana
Phone: 734-712-3671
Click here to add this to my saved trials
Fort Myers, Florida 33908
Principal Investigator: Emad K. Salman
Phone: 239-343-5333
Click here to add this to my saved trials
Cook Children's Medical Center Cook Children's Health Care System is a not-for-profit, nationally recognized pediatric...
Click here to add this to my saved trials
1600 Southwest Archer Road
Gainesville, Florida 32610
Gainesville, Florida 32610
Principal Investigator: William B. Slayton
Click here to add this to my saved trials
900 West Faris Rd.
Greenville, South Carolina 29605
Greenville, South Carolina 29605
(864)455-8898
Principal Investigator: Nichole L. Bryant
Phone: 864-241-6251
BI-LO Charities Children's Cancer Center The BI-LO Charities Children
Click here to add this to my saved trials
30 Prospect Ave
Hackensack, New Jersey 07601
Hackensack, New Jersey 07601
(201) 996-2000
Principal Investigator: Michael B. Harris
Phone: 201-996-2879
Hackensack University Medical Center Hackensack University Medical Center, part of the Hackensack University Health Network,...
Click here to add this to my saved trials
Hollywood, Florida 33021
Principal Investigator: Iftikhar Hanif
Phone: 954-265-2234
Click here to add this to my saved trials
Click here to add this to my saved trials
1319 Punahou St
Honolulu, Hawaii 96826
Honolulu, Hawaii 96826
(808) 983-6000
Principal Investigator: Wade T. Kyono
Phone: 808-983-6090
Kapiolani Medical Center for Women and Children Hawai‘i Pacific Health is an integrated health care...
Click here to add this to my saved trials
Houston, Texas 77030
Principal Investigator: Julienne Brackett
Phone: 713-798-1354
Click here to add this to my saved trials
Las Vegas, Nevada 89109
Principal Investigator: Nik F. Nik Abdul Rashid
Phone: 702-384-0013
Click here to add this to my saved trials
Las Vegas, Nevada 89135
Principal Investigator: Nik F. Nik Abdul Rashid
Phone: 702-384-0013
Click here to add this to my saved trials
1 Medical Center Dr
Lebanon, New Hampshire 03756
Lebanon, New Hampshire 03756
(603) 650-5000
Principal Investigator: Julie Kim
Phone: 800-639-6918
Dartmouth Hitchcock Medical Center Dartmouth-Hitchcock is a national leader in patient-centered health care and building...
Click here to add this to my saved trials
1 Children's Way
Little Rock, Arkansas 72202
Little Rock, Arkansas 72202
(501) 364-1100
Principal Investigator: David L. Becton
Phone: 501-364-7373
Arkansas Children's Hospital Arkansas Children's Hospital (ACH) is the only pediatric medical center in Arkansas...
Click here to add this to my saved trials
Click here to add this to my saved trials
9000 W Wisconsin Ave #270
Milwaukee, Wisconsin 53226
Milwaukee, Wisconsin 53226
(414) 266-2000
Principal Investigator: Richard L. Tower
Phone: 414-955-4727
Children's Hospital of Wisconsin Nothing matters more than our children. At Children's Hospital of Wisconsin,...
Click here to add this to my saved trials
New Haven, Connecticut 6520
(203) 432-4771
Principal Investigator: Nina S. Kadan-Lottick
Phone: 203-785-5702
Yale University Yale's roots can be traced back to the 1640s, when colonial clergymen led...
Click here to add this to my saved trials
New Hyde Park, New York 11040
Principal Investigator: Jonathan D. Fish
Phone: 718-470-3470
Click here to add this to my saved trials
New Orleans, Louisiana 70121
Principal Investigator: Craig Lotterman
Phone: 504-703-8712
Click here to add this to my saved trials
Oak Lawn, Illinois 60453
Principal Investigator: Rebecca E. McFall
Phone: 847-723-7570
Click here to add this to my saved trials
940 NE 13th St
Oklahoma City, Oklahoma 73190
Oklahoma City, Oklahoma 73190
(405) 271-6458
Principal Investigator: Rene Y. McNall-Knapp
Phone: 405-271-8777
University of Oklahoma Health Sciences Center The OU Health Sciences Center is composed of seven...
Click here to add this to my saved trials
725 Welch Rd
Palo Alto, California 94304
Palo Alto, California 94304
(650) 497-8000
Principal Investigator: Sheri L. Spunt
Lucile Packard Children's Hospital Stanford University Stanford Children's Health is the only network in the...
Click here to add this to my saved trials
Click here to add this to my saved trials
3601 A St
Philadelphia, Pennsylvania 19134
Philadelphia, Pennsylvania 19134
(215) 427-5000
Principal Investigator: Gregory E. Halligan
Phone: 215-427-8991
Saint Christopher's Hospital for Children St. Christopher's Hospital for Children offers a wide range of...
Click here to add this to my saved trials
2801 N Gantenbein Ave
Portland, Oregon 97227
Portland, Oregon 97227
(503) 276-6500
Principal Investigator: Janice F. Olson
Legacy Emanuel Children's Hospital For generations our children's hospital has provided outstanding care for kids...
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
4800 Sand Point Way NE
Seattle, Washington 98105
Seattle, Washington 98105
(206) 987-2000
Principal Investigator: Douglas S. Hawkins
Phone: 866-987-2000
Seattle Children's Hospital Seattle Children’s Hospital specializes in meeting the unique physical, emotional and developmental...
Click here to add this to my saved trials
101 W 8th Ave
Spokane, Washington 99204
Spokane, Washington 99204
(509) 474-3131
Principal Investigator: Judy L. Felgenhauer
Providence Sacred Heart Medical Center & Children's Hospital When Mother Joseph and the Sisters of...
Click here to add this to my saved trials
101 Nicolls Rd
Stony Brook, New York 11794
Stony Brook, New York 11794
(631) 444-4000
Principal Investigator: Laura E. Hogan
Phone: 800-862-2215
Stony Brook University Medical Center Stony Brook Medicine expresses our shared mission of research, clinical...
Click here to add this to my saved trials
Tampa, Florida 33607
Principal Investigator: Mark J. Mogul
Phone: 813-287-6306
Click here to add this to my saved trials
Tucson, Arizona 85724
Principal Investigator: Yi Zeng
Phone: 520-626-9008
Click here to add this to my saved trials
901 45th St
West Palm Beach, Florida 33407
West Palm Beach, Florida 33407
(561) 844-6300
Principal Investigator: Narayana Gowda
Phone: 888-823-5923
Saint Mary's Hospital Our team of dedicated physicians, nurses and staff offer a broad spectrum...
Click here to add this to my saved trials
1 Medical Center Blvd
Winston-Salem, North Carolina 27157
Winston-Salem, North Carolina 27157
336-716-2011
Principal Investigator: Thomas B. Russell
Phone: 336-713-6771
Wake Forest University Health Sciences Welcome to Wake Forest Baptist Medical Center, a fully integrated...
Click here to add this to my saved trials